Laparoscopic Nissen Versus Toupet Fundoplication for Hiatal Hernia.
1 other identifier
interventional
200
1 country
1
Brief Summary
This randomized controlled trial compares laparoscopic Nissen fundoplication and laparoscopic Toupet fundoplication in patients undergoing surgical treatment for hiatal hernia associated with gastroesophageal reflux disease. Participants will be randomly assigned to one of two surgical groups. The study will evaluate postoperative pain, health-related quality of life, hospital stay, recurrence of reflux symptoms, gas-bloat symptoms, operative time, fundoplication time, and postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2023
CompletedFirst Submitted
Initial submission to the registry
June 19, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
ExpectedJuly 22, 2026
July 1, 2026
3.2 years
June 19, 2026
July 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Postoperative pain score at 24 hours
Postoperative pain will be assessed 24 hours after surgery using the Visual Analog Scale. The score will be used to compare early postoperative pain between participants undergoing laparoscopic Nissen fundoplication and those undergoing laparoscopic Toupet fundoplication.
24 hours after surgery
Postoperative Pain Score at 7 Days
Postoperative pain will be assessed 7 days after surgery using the Visual Analog Scale. The score will be used to evaluate and compare short-term postoperative pain between the two intervention groups.
7 days after surgery
Change in Health-Related Quality of Life After Surgery
Health-related quality of life will be assessed using the GERD-Health Related Quality of Life questionnaire. Preoperative scores will be compared with postoperative scores in order to evaluate changes in reflux-related symptoms and quality of life after laparoscopic Nissen or Toupet fundoplication.
Preoperatively, 1 week, 4 weeks
Postoperative Hospital Stay
Postoperative hospital stay will be measured as the number of days from the day of surgery until hospital discharge. The duration of hospital stay will be compared between the Nissen and Toupet fundoplication groups.
From the day of surgery until hospital discharge - up to 30days
Recurrence of Gastroesophageal Reflux Symptoms
Recurrence of gastroesophageal reflux symptoms will be assessed during postoperative follow-up. The presence or absence of recurrent reflux symptoms will be recorded and compared between the two intervention groups.
4 weeks and 1 year after surgery
Secondary Outcomes (4)
Operative Timе
Intraoperative
Fundoplication Time
Intraoperative
Gas-Bloat Symptoms
3 days; 1 week
Postoperative Complications
Up to 30 days after surgery
Study Arms (2)
Nissen fundoplication
ACTIVE COMPARATORParticipants assigned to this arm will undergo laparoscopic hiatal hernia repair with Nissen fundoplication. The procedure includes a complete 360° fundoplication performed as part of standard laparoscopic antireflux surgery.
Toupet Fundoplication
ACTIVE COMPARATORParticipants assigned to this arm will undergo laparoscopic hiatal hernia repair with Toupet fundoplication. The procedure includes a partial posterior 270° fundoplication performed as part of standard laparoscopic antireflux surgery.
Interventions
The procedure includes a complete 360° fundoplication performed as part of standard laparoscopic antireflux surgery.
The procedure includes a partial posterior 270° fundoplication performed as part of standard laparoscopic antireflux surgery.
Eligibility Criteria
You may qualify if:
- Patients aged 18 to 90 years
- Patients diagnosed with primary hiatal hernia by fibrogastroscopy and/or barium swallow examination
- Patients with symptoms of gastroesophageal reflux disease
- Patients scheduled for elective laparoscopic hiatal hernia repair with fundoplication
- Patients able to provide informed consent
You may not qualify if:
- Patients younger than 18 years or older than 90 years Patients with recurrent hiatal hernia Patients who are not suitable for general anesthesia Patients who prefer a surgical approach other than laparoscopic surgery Patients who are unable or unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMHAT Sofiamed
Sofia, Sofia-Grad, 1517, Bulgaria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and the postoperative outcomes assessor will be masked to the type of fundoplication performed. The operating surgeon and operating room staff cannot be masked due to the nature of the surgical intervention. Operative details regarding the type of fundoplication will not be disclosed to the participant or the outcomes assessor before postoperative assessments are completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
June 19, 2026
First Posted
July 22, 2026
Study Start
May 29, 2023
Primary Completion
July 30, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share